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Background. Ovarian cancer has the highest mortality rate of gynaecological cancers. This is partly due to 
the lack of effective screening markers. Indices of oxidative stress are well-recognized prognostic criteria for 
tumorous transformation of tissue, but their value depends on the type of tumor and the stage of its deve-
lopment. 
Objective. The aim of this study is to clarify the relationship between antioxidant/pro-oxidant ratio and the 
signs of molecular lesions and apoptosis rate in blood of ovarian cancer patients and non-cancer ones.
Results. The ovarian cancer group is marked by antioxidant/prooxidant balance shifting to oxidative damage 
in blood as the consequence of overexpression of oxyradicals (by 300%). Higher level of glutathione (by 366%), 
lower level of metallothioneins (by 65%) as well as higher level of lipid peroxidation (by 174%) and protein carbonyls 
(by 186%) in blood of ovarian cancer patients compared to the normal ovarian group have been observed. The 
signs of cytotoxicity are determined in blood of ovarian cancer patients: an increased (compared to control) level 
of DNA fragmentation (by 160%), choline esterase (up to twice), higher rate of both caspase dependent and 
caspase independent lysosomal mediated apoptosis. 
Conclusions. Cathepsin D activity both total and free, choline esterase activity, TBA-reactive substance and 
protein carbonyls level in blood could be used as the predictive markers of worse prognosis and the signs of 
human ovarian cancer.
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Introduction
Ovarian cancer dominates among the death 
causes of malignant tumours. In particular, 
according to the International Agency for 
Cancer Research, more than 165 thousand of 
newly diagnosed cases of ovarian cancer are 
registered each year over the world. Despite 
intensive studies, every year, more than 100 000 
women die from this disease worldwide. Due 
to minimal and non-specific early stage symp-
toms, ovarian cancer diagnosis is late and pro-
gnosis is usually poor [1]. Currently there are 
no screening programs for precancerous and 
malignant ovarian pathology diagnostic, with 
the help of which specialists could have reduced 
the incidence and fatalities of this disease [2]. 
Therefore, exploration of new and/or low-cost 
early-warning molecular signatures of disease 
is a key goal of ovarian cancer research.
One of the most common mechanisms of 
diseases development and aggressiveness of 
pathology which is on the focus of biomedical 
research has been linked to overexpression of 
free radicals and oxidative stress initiation [3, 
4, 5, 6, 7]. The damage that reactive oxygen 
species (ROS) can cause to the cell not only 
depends on their internal concentration but 
also on the equilibrium between the ROS and 
the endogenous antioxidants normally protect 
cells against oxidative stress [4, 6]. When the 
antioxidant/prooxidant system becomes un-
balanced, oxidative stress is generated, altering 
and damaging many biomolecules, including 
DNA, lipids and proteins, in turn, decreasing 
cell viability [5, 6, 8, 9]. We have shown before 
that higher content of the products of oxidative 
damage of proteins, lipids, DNA fragmentation 
and cathepsin D activity, particularly free one 
are the main characteristic signs of malignant 
ovarian tissue [10]. However, it can be difficult 
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to obtain a biopsy from ovarian tissue for rou-
tine biochemical measurements with pro gnos-
tic mission of diseases development. Instead 
of them correspondent blood test would be 
highly recommended. Thus, here we aim to 
clarify the relationship between anti oxi dant/
pro-oxidant ratio and the signs of mo le cular 
lesions and apoptosis rate in blood of ova rian 
cancer patients and normal ovarian ones. 
Materials and Methods
For this research we used the venous blood 
samples taken from the 15 newly diagnosed 
patients of reproductive age who had been 
operated for epithelial ovarian cancer at the 
Department of Gynaecology of Ternopil Regio-
nal Oncological Hospital. Cancer pathology was 
verified histologically. According to FIGO clas-
sification, all diagnosed patients had stage III 
disease. None of the operated oncologic female 
patients had been previously treated with 
platinum-based drugs (cisplatin/carbo platin/
cycloplatam) or cyclophosphamide. Venous 
blood of 15 females not affected by the relevant 
pathology were taken as controls. All experi-
mental studies were conducted in accordance 
with the rules of the National Congress on 
Bioethics (Kyiv, 2000) and the decision of the 
Commission on Bioethics of the Ternopil State 
Medical University (№ 3, 2013).
All the procedures on bloods were carried 
out at 4o C. All the reagents, except those spe-
cified below, were produced by “Synbias”, 
‘chemically pure’ grade.
The determination was conducted in the 
soluble fraction of blood, which had been re-
cei ved to determine superoxide dismutase 
(SOD) as a result of centrifugation of blood 
within 10 min at 6000 g (S6), to determine the 
level of oxygen radicals – as a result of its centri-
fugation within 45 min at 12 000 g (S12) and to 
determine the concentration of metallo thio-
neins – within 45 min at 16 000 g (S16).
Superoxide dismutase activity (SOD) (EC 
1.15.1.1) was measured by a decrease in the 
rate of the reduction of Nitrotetrazolium blue 
in the presence of phenazine methosulfate and 
NADH [11]. Enzymatic activity was expressed in 
conventional units (CU). Enzyme activity, which 
was able to cause a decrease in optical density 
in the process of the reduction of Nitrotetrazolium 
blue in 50% test sample per 1 mg of protein 
from the homogenate in soluble form, was 
taken as 1 CU.
The content of total glutathione was deter-
mined in blood after complete reduction of 
glutathione through the use of glutathione 
reductase (Sigma, USA) and with the help of 
Ellman’s reagent [12]. The level of 5-trinitro-
benzoic acid was monitored with a spectropho-
tometer at 412 nm. 
The determination of protein carbonyls (PC) 
was conducted due to their ability to form 2,4-
dinitrophenylhydrazones under the blood plas-
ma incubation in the presence of 0.1 M 2,4-dinit-
rophenylhydrazine in HCl, 2 M. The light absor-
bance was registered at 370 nm against the 
control, and the content of phenylhydrazone 
was calculated using a molar extinction coeffi -
cient of 2.1×104 M-1cm-1[13]. Lipid peroxidation 
was characterized by the products of interaction 
between deproteinized blood after precipitation 
of proteins with trichloroacetic acid (with final 
concentration of 5%) from blood samples and 
2-thiobarbituric acid (TBA). The formation of 
TBA-reactive substance (TBARS) was calculated 
by the intensity of the absorption of a pink-
coloured complex at 532 nm by the molar 
extinction coefficient of the complex equal to 
ε=1.56×105 М–1cm–1 [14].
The content of oxyradicals (OR) in S12 frac-
tion of the blood plasma was evaluated using 
the non-fluorescent derivative, dihydror hoda-
mine, which is converted to the fluorescent dye, 
rhodamine-123, after a reaction with re active 
oxygen species. The fluorescence sig nal was 
detected by using an f-max fluorescence plate-
reader [excitation=485 nm, emission=538 nm] 
immediately and after 20 min and used to 
deter mine the rate of ROS formation [10, 15] 
and expressed in relative fluorescence units 
(RFU) per 1 mg of protein.
The content of metallothioneins (MTs) in 
S16 fraction of blood was evaluated by the con-
tent of thiol groups (MT-SH) with slight modi-
fication [8, 9, 10, 16] with 5,5'-dithio-bis-2-nitro-
benzoic acid (DTNB, Sigma, USA) after the 
chloroform-ethanol extraction of MT, and calcu-
lated assuming that 1 mol of MT contains the 
same amount of SH-groups as 20 moles of 
GSH. 
Choline esterase (ChE, EC 3.1.1.7) activity 
was determined in blood as the acetylthiocholine-
cleaving ChE activity according to the colo-
rimetric method of Ellman et al. (1961) at 25oC 
[17]. Enzyme activity was calculated using a 
molar extinction coefficient of 13.6×103 М–1сm–1 
and standardized to the soluble protein 
content.
DNA damage was determined by the con-
tent of the fragmented deproteinized DNA in 
the total DNA by the method of alkaline pre-
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cipitation of 10% blood plasma in 50 mM Tris-
EDTA buffer, pH 8.0, containing 0.5% sodium 
dodecyl sulfate (Sigma, USA). The supernatant 
contains damaged DNA molecules when the 
pellet contains protein and a whole DNA. DNA 
content in the supernatant and in the pellet was 
determined by the Hoescht dye in the presence 
of 0.4 M NaCl, 4 mM of sodium cholate and 
0.1 M Tris (pH 9.0) at the excitation wave 
(ex.)=360 nm and emission (em.)=450 nm [18]. 
The content of fragmented DNA was expres-
sed as a percentage to the total DNA in the 
sample.
Caspase-3 activity in blood samples was 
measured using a colorimetric assay based on 
the hydrolysis of peptide acetyl-Asp-Glu-Val-Asp 
p-nitroanilide (Ac-DEVD-pNA) by caspase-3, 
resulting in a release of the p-nitroaniline (pNA) 
moiety. p-Nitroaniline was detected at 405 nm 
(εM=10,500 M-1cm -1) [19, 20].
The enzymatic activity of cathepsin D (EC 
3.4.23.5) was determined spectrophotometrically 
by the formation of acid-soluble products of 
hemoglobin enzymatic hydrolysis [10, 21]. The 
reaction mixture contained 50% blood serum 
in 0.25 M of sucrose solution and, as a substrate, 
1% solution of bovine hemoglobin (Sigma, USA) 
in 0.1 M acetate buffer (pH 5.0). The enzymatic 
reaction was stopped by adding 10% solution 
of trichloracetic acid up to a final concentration 
of 2%. To determine the total activity of cathe-
psin D, the blood serum sample was previously 
treated with 1% solution of Triton X-100 (Sigma, 
USA) for 10 min at +37оС. The control sample 
was incubated at +4оС for 30 min before adding 
10% trichloracetic acid solution. The activity of 
cathepsin D was calculated by the difference in 
the optical density of experimental and control 
samples at 280 nm wave length and expressed 
as nmol of tyrosine/(min×mL).
The results of the measurements were 
presented as means ± standard deviation (SD) 
M±SD for 15 samples of the blood of the ovarian 
cancer patients and the reference group. If the 
data was not normally distributed according to 
the Lilieford test, it had been transformed using 
the Box-Cox method. For the data that were not 
normally distributed even after the transfor-
mation, non-parametric tests (Kruskall–Wallis 
ANOVA and Mann–Whitney U-test) were perfor-
med. Differences were considered significant 
if the probability of Type I error was less than 
0.05. For evaluation of the antioxidative-pro oxi-
dative equilibrium we proposed the Integrated 
Oxidative Stress (IOS) index as the ratio of 
antioxidant factors (SOD, GSH and MT-SH level) 
and prooxidant manifestations (oxyradicals 
(OR), TBARS and PC) after the standardization 
of data [8, 9]. The main classification criterion 
and relationship between biochemical para-
meters of the ovarian tissue samples was 
evaluated using the discriminant analysis and 
correlation analysis (Pearson’s correlation 
coefficient r under the probability of the value 
p<0.05). All statistical calculations were perfor-
med by means of Statistica v10.0 and Excel for 
Windows 2010.
Results and Discussion
The results of an evaluation of antioxidant 
defense system parameters (Table 1) show 
glutathione level (by 366%) in blood of the 
cancer patients is higher than in the control 
ones and SOD activity just commensurate in 
both groups. The MT-SH level (by 65%) is lower 
under the ovarian cancer. At the same time, the 
intensity of the oxyradicals formation (by 300%), 
the concentration of TBARS (by 174%) and 
protein carbonyls (by 186%) are higher in the 
blood of the cancer patients compared to the 
correspondent control ones. 
The signs of cytotoxicity are determined in 
blood of the ovarian cancer patients: an 
increased (compared to the control ones) level 
of DNA fragmentation (by 160%), caspase-3 
activity (by 43%) and cathepsin D activity, both 
of its total (by 546%) and, particularly, free 
forms (by 952%). The activity of choline esterase 
is twice as high as in the ovarian cancer group 
compared to the intact one.
The application of discriminant functional 
analysis (a subtype of the multivariate data 
analysis) to the set of studied biochemical 
parameters has shown that the characteristics 
of cathepsin D activity both total and free, 
choline estrase activity, TBARS and protein 
carbonyls level are the main criteria for differen-
tiation of the studied groups (F(11,18)=2353,6, 
p<0,0000). For an appreciation of the quantitative 
equilibrium between antioxidant defence and 
oxidative destruction, we calculated the IOS 
index after standardizing the data. It was lower 
in blood of the cancer patients (IOS=-39%) 
indicating the balance shifting to oxidative 
damage as the consequence of tolerance limits 
of antioxidant defence system increased in 
ovarian cancer patient.
Recent studies have shown an important 
role for reactive oxygen species (ROS) in cancer 
development [5]. ROS can be produced in dif-
ferent endogenous sources, such as mito chon-
dria, peroxisomes etc. [3] and are accu mulated 
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under an imbalance between their production 
and elimination by protective mechanisms, 
referred to as antioxidants. ROS are overpro-
duced a long time, then, may cause DNA, pro-
tein, and/or lipid damage [7]. In our case the 
ovary cancer is also said to be under oxidative 
stress (IOS less than zero) associates with the 
most prominent upraise of oxidative lesions 
(triple of them, TBARS, protein carbonyls and 
oxyradicals). We speculate that oxidative stress 
causes injury to cells, among them initiation of 
DNA strand breaks (DNAsb=1.65–0.02×TBARS+ 
1.93×PC*+0.65×OR*, R2=0.98, F(6,23)=212,69, 
p<0.001; * – parameter makes a presumable 
con tri bution to the mathematical model) and 
liberation of cathepsin D from lysosomes 
(Cathepsin D(free) = –3.69+0.19×TBARS*+0.78×
PC+0.48×OR, R2=0.96, F(6,23)=210,05, p<0.001). 
It is established that cathepsins, released from 
lysosomes in course of oxidative injury of 
membranes [22], cleave Bid, which activates the 
mitochondrial apoptosis pathway [23]. Thus, 
human ovary cancer progression is linked to 
oxidative stress directly by increasing DNA 
fragmentation and caspase-independent lyso-
somal-mediated apoptosis pathway. 
A failure to undergo apoptosis is considered 
to be a key event in cancer formation and pro-
gression [24]. Using the key mediators of 
mitochondrial events of apoptosis, caspase 3, 
we have shown that ovarian cancer exhibits 
higher rates of apoptosis than either samples 
of the control group. Data about caspase 3 role 
in cancer progress and patients survival are 
controversial; and it has been demonstrated 
that expression of caspase-3 does not correlate 
with the extent of apoptosis in primary car-
cinomas [25]. Some investigators have also 
reported increased rates of apoptosis in dif fe-
rent types of cancer, breast carcinomas among 
them. But, on the other hand, it has been shown 
that loss of caspase-3 expression may decrease 
breast cancer cells resistant to chemotherapy 
and radiation therapy [26].
Many studies have found that the expression 
level of AChE and/or BChE increases during 
apoptosis in various cell types and alter human 
breast, lung cancer, leukemia etc progress [27]. 
Many tumours, including ovarian carcinoma, 
express ChEs, indicating that the enzymes may 
be functionally important in neoplastic cell 
transformation, and can be considered a mar-
ker of early differentiation [28]. In breast cancer 
AChE activity is as in twice as high as in normal 
breast. The difference in lectin reactivity bet-
ween erythrocyte and breast AChE, the lack of 
AChE in blood plasma suggest that breast 
epithelial cells produce AChE for membrane 
attachment [27]. It has also been demonstrated 
that AChE can hydrolyse lipid peroxides, which 
may support the possibility that a reduction in 
enzyme activity augments oxidative stress and 
cellular damage of bronchopulmonary epithelial 
cells [29]. We have also shown in our study the 
concordant changes of choline esterase and 
caspase-3 activity (r=0.83, p<0.001) strongly 
suggest that ChE is an important component 
in the common pathway leading to apoptosis 
in human ovarian cancer and future studies of 
such mechanisms would be of great interest.
Several in vitro studies have demonstrated 
the importance of MTs expression for cancer cell 
growth and survival. On the one hand over exp-
ression of MTs has been reported for different 
type of cancers and MT levels have been 
correlated with increasing tumour grade in 
different ones [30, 31]. But, on the other hand, 
the downregulation of MT protein pro duction 
Table 1. Biochemical parameters in blood of ovarian cancer and normal ovarian patients,  
M±SD, n=15 
Parameter GroupsNormal ovarian Ovarian cancer
MT-SH content, µg⋅mL-1 of blood 16.2±1.9 5.6±0.7*
Total glutathione content, mmol⋅L-1 of blood 0.9±0.1 4.2±0.8*
SOD activity, CU⋅mg-1 of protein 1.8±0.2 1.6±0.2
TBARS content, nmol⋅mL-1 of blood 19.4±2.5 53.1±6.2*
Protein carbonyls level, nmol⋅mg-1 of plasma proteins 0.7±0.2 2.0±0.3*
Cholin esterase, nmol⋅min-1⋅mg-1 proteins 0.38±0.04 1.25±0.18*
Oxygen radicals content, RFU⋅mg-1 of protein 0.94±0.08 3.76±0.42*
Caspase-3, pmol⋅min-1⋅mg-1 proteins 7.7±0.8 11.0±1.3*
Total activity of cathepsin D, nmol⋅min-1⋅mL-1 of blood serum 2.2±0.3 14.2±1.2*
Free cathepsin D activity, nmol⋅min-1⋅mL-1 of blood serum 0.96±0.07 10.10±0.89*
Content of fragmented DNA in total DNA, % 3.0±0.4 7.8±0.5*
Note. * – differences compared to the blood samples of the reference group, р<0.05.
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resulted in dramatic growth inhibition of several 
human cancer cell lines. Similarly, when MT 
expression was abolished in human PC-3 
prostate and SKOV-3 ovarian cancer cell lines 
using a specific ribozyme, there is a marked 
increase in spontaneous apoptosis [32]. We have 
also found that lower level of MTs in ovarian 
cancer group potentially caused the caspase-
dependent apoptosis pathway activa tion 
(r=-0.86, p<0.001). We speculate that apo ptotic 
activation is dependent on MTs levels via zinc, 
because it is a potent inhibitor of caspase-3 [33]. 
It is recognised that depletion of zinc by chelation 
has been shown to promote apoptosis in vitro 
[34]. Therefore, zinc bound to MTs may play a 
crucial role in the control of apoptosis. Apoptosis 
rate would be as higher as less zinc is liberated 
in cells containing less MTs. Our present findings 
are in good correlation with our previous work 
that demonstrated decreased zinc concentration 
in the samples of ovarian cancer tissue compared 
with normal ovarian [10]. 
Conclusions
Using the multi-marker analysis of stress-
related processes in the ovarian cancer we 
determined a number of blood characteristics, 
which compound the pathological changes in 
the malignant tissue; the imbalance between 
antioxidants and oxidative lesions, appearance 
of DNA strand breaks and activation of both 
caspase dependent and caspase independent 
lysosomal mediated apoptosis pathway are 
among them. Cathepsin D activity, both total 
and free, choline esterase activity, TBARS and 
protein carbonyls level can be used as the 
predictive markers of worse prognosis and the 
signs of human ovarian cancer. Metallothioneins 
down-regulation and choline esterase activation 
in blood are ultimately resulting in intrinsic 
apoptosis pathway in ovarian cancer. The 
further studies are needed to elucidate the 
mechanism by which choline esterase regulates 
caspase-3 dependent apoptosis in human 
ovarian cancer.
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